Related Experiment Video
Updated: Dec 1, 2025

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
Extracellular adenosine 5'-triphosphate in pulmonary disorders
1Danmir Therapeutics, LLC, Haverford, PA, USA. Electronic address: http://www.danmirtherapeutics.com.
Adenosine triphosphate (ATP) released from cells signals through P2 receptors, influencing lung inflammation. Targeting ATP pathways offers new treatments for pulmonary diseases like fibrosis and lung injury.
Area of Science:
- Biochemistry
- Cell Biology
- Pulmonology
Background:
- Adenosine triphosphate (ATP) is vital for cellular energy and metabolism.
- Extracellular ATP acts as a signaling molecule before degradation by ecto-enzymes.
- ATP signaling via P2 purinergic receptors is implicated in various physiological and pathophysiological processes.
Purpose of the Study:
- To review the role of ATP in pulmonary inflammation.
- To summarize ATP's involvement in bronchoconstriction, cough, ventilator-induced lung injury, and idiopathic pulmonary fibrosis.
- To highlight ATP-signaling pathways as potential therapeutic targets for lung diseases.
Main Methods:
- Literature review of studies on ATP signaling in pulmonary disorders.
- Analysis of the function of P2 purinergic receptors in lung cells.
- Summary of evidence linking extracellular ATP to inflammatory processes in the lungs.
Main Results:
- Extracellular ATP activates P2 purinergic receptors on lung cells.
- ATP signaling contributes to bronchoconstriction, cough, and lung injury.
- Dysregulated ATP signaling is observed in idiopathic pulmonary fibrosis and other lung conditions.
Conclusions:
- ATP plays a significant role in pulmonary inflammation and related disorders.
- Targeting ATP-signaling pathways presents a promising strategy for novel drug development.
- Further research into ATP pathways could lead to improved treatments for unmet clinical needs in lung disease.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
ATP Energy Storage and Release
One example of energy coupling using ATP involves a...
Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Other Pulmonary Disorders

